Assessing Quality of Care for the Myelodysplastic Syndromes (Q38937504)

7 September 2017

1 reference

title

Assessing Quality of Care for the Myelodysplastic Syndromes (English)

1 reference

7 September 2017

0 references

Zachary A K Frosch

1

1 reference

PubMed ID

27562670

7 September 2017

Gregory A Abel

series ordinal

2

1 reference

7 September 2017

25 August 2016

1 reference

Current hematologic malignancy reports

7 September 2017

1 reference

7 September 2017

11

1 reference

7 September 2017

6

1 reference

7 September 2017

402-407

1 reference

https://scigraph.springernature.com/pub.10.1007/s11899-016-0343-0

7 September 2017

0 references

cites work

Measuring quality in oncology: challenges and opportunities.

1 reference

https://api.crossref.org/works/10.1007%2FS11899-016-0343-0

Myelodysplastic Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-016-0343-0

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-016-0343-0

Age and comorbidities deeply impact on clinical outcome of patients with myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-016-0343-0

Change of prognosis of patients with myelodysplastic syndromes during the last 30 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-016-0343-0

Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-016-0343-0

The costs of drugs used to treat myelodysplastic syndromes following National Comprehensive Cancer Network Guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-016-0343-0

Patterns of erythropoiesis-stimulating agent use among Medicare beneficiaries with myelodysplastic syndromes and consistency with clinical guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-016-0343-0

Improving the diagnosis and treatment of patients with myelodysplastic syndromes through a performance improvement initiative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-016-0343-0

Setting value-based payment goals--HHS efforts to improve U.S. health care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-016-0343-0

Hospice Use Among Patients With Lymphoma: Impact of Disease Aggressiveness and Curability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-016-0343-0

Aggressiveness of cancer care near the end of life: is it a quality-of-care issue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-016-0343-0

Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-016-0343-0

International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-016-0343-0

Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-016-0343-0

Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-016-0343-0

Factors associated with hematopoietic cell transplantation (HCT) among patients in a population-based study of myelodysplastic syndrome (MDS) in Minnesota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-016-0343-0

Differences in community and academic practice patterns for newly diagnosed myelodysplastic syndromes (MDS) patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-016-0343-0

Effects of individual physician-level and practice-level financial incentives on hypertension care: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-016-0343-0

The effect of financial incentives on the quality of health care provided by primary care physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-016-0343-0

Fatigue and mortality: from description to action

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Classification of the myelodysplastic syndrome in a national registry of recently diagnosed patients

1 reference

12 December 2020

The long-term effect of premier pay for performance on patient outcomes

1 reference

12 December 2020

The quality of care. How can it be assessed?

1 reference

12 December 2020

Myelodysplastic syndromes

1 reference

12 December 2020

Evaluating the quality of medical care.

1 reference

12 December 2020

Financial incentives in primary care practice: the struggle to achieve population health goals

1 reference

12 December 2020

Hyporesponsiveness to erythropoietin: overview, 1996

1 reference

12 December 2020

10.1007/S11899-016-0343-0

Identifiers

DOI

1 reference

PubMed ID

27562670

Dimensions Publication ID

7 September 2017

0 references

1 reference

PubMed ID

27562670